» Articles » PMID: 30823902

Updating the Role of Obesity and Cholesterol in Breast Cancer

Overview
Specialty Oncology
Date 2019 Mar 3
PMID 30823902
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer is the second most common cause of cancer-related death among women. Advances in our understanding of the disease have translated into better diagnostics and more effective therapeutics, leading to earlier detection and improved outcomes. Several studies have pointed at lifestyle and environmental factors as contributory for the onset and progression of the disease. Obesity and cholesterol stand out for their potential causal relationship with breast cancer and ease of modification.

Main Text: Obesity and cholesterol represent risk factors for breast cancer, but their impact is largely affected by cofounding variables including menopausal status, disease subtype, and inflammation. Establishing a causal relationship between lifestyle factors and clinical outcomes may be challenging. Epidemiological studies and meta-analyses have rendered conflicting or sometimes contradictory results, possibly owing to the multifactorial nature of the disease. We discuss the supporting evidence and limitations in our understanding of obesity and cholesterol as risk factors for breast cancer.

Conclusions: There is sufficient evidence that obesity and cholesterol impact clinical outcomes. Physicians are advised to take steps to help patients with their weight, such as recommending dietary and lifestyle interventions.

Citing Articles

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z Mol Cancer. 2025; 24(1):61.

PMID: 40025508 PMC: 11874147. DOI: 10.1186/s12943-025-02258-1.


Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data.

Araujo D, Simoes R, Sabino A, Oliveira A, Oliveira C, Veloso A Med Biol Eng Comput. 2025; .

PMID: 39828884 DOI: 10.1007/s11517-025-03289-y.


A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor.

Mei W, Faraj Tabrizi S, Godina C, Lovisa A, Isaksson K, Jernstrom H Cell. 2024; 188(2):371-389.e28.

PMID: 39657676 PMC: 11770377. DOI: 10.1016/j.cell.2024.11.009.


Breast cancer and its determinants in Ethiopia: a systematic review and meta-analysis.

Shama A, Terefa D, Desisa A, Lema M, Cheme M, Geta E BMJ Open. 2024; 14(11):e080080.

PMID: 39488422 PMC: 11535668. DOI: 10.1136/bmjopen-2023-080080.


Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits.

Pyo Y, Kwon K, Jung Y Foods. 2024; 13(14).

PMID: 39063337 PMC: 11276387. DOI: 10.3390/foods13142253.


References
1.
Must A, Spadano J, Coakley E, Field A, Colditz G, Dietz W . The disease burden associated with overweight and obesity. JAMA. 1999; 282(16):1523-9. DOI: 10.1001/jama.282.16.1523. View

2.
Enger S, Ross R, Paganini-Hill A, Carpenter C, Bernstein L . Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev. 2000; 9(7):681-7. View

3.
Ishikawa M, Kitayama J, Nagawa H . Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res. 2004; 10(13):4325-31. DOI: 10.1158/1078-0432.CCR-03-0749. View

4.
Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005; 46(11):2347-55. DOI: 10.1194/jlr.M500294-JLR200. View

5.
Housa D, Housova J, Vernerova Z, Haluzik M . Adipocytokines and cancer. Physiol Res. 2005; 55(3):233-244. DOI: 10.33549/physiolres.930848. View